Synopsis
Leveraging outsourced compounders’ offerings remains a key focus in hospital pharmacy practice. According to Pharmacy Purchasing and Products’ 2024 State of Pharmacy Compounding survey, 73% of all facilities outsource at least some portion of their compounded preparations.1 When choosing a 503B outsourcing partner, performing the requisite due diligence is critical to ensuring the chosen vendor(s) operates safely and in compliance with all regulations and requirements. Developing and implementing vendor selection guidelines is essential for procuring any outsourced compounded non-sterile preparations (CNSP) or sterile preparations (CSPs) used by their organization and patients under their care.
